Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation.

about

Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation.

Item

http://www.wikidata.org/entity/Q42239843

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@en

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@nl

type

Item

label

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@en

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@nl

prefLabel

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@en

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@nl

P1476

Anti-Erythropoietin Antibody A ...... d after Liver Transplantation.

@en

P2093

Annie K Hung

http://www.w3.org/2001/XMLSchema#string

Caroline M Behler

http://www.w3.org/2001/XMLSchema#string

Eugene E Lee

http://www.w3.org/2001/XMLSchema#string

Jennifer Guy

http://www.w3.org/2001/XMLSchema#string

P2860

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage

Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.

Peginesatide in patients with anemia undergoing hemodialysis.

Anti-erythropoietin antibodies and pure red cell aplasia.

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.

Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options.

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.

Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report.

P304

286276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/286276

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280691841

http://www.w3.org/2001/XMLSchema#string

P698

26240773

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

Erythropoietin

P932

4512579

http://www.w3.org/2001/XMLSchema#string